0 NASDAQ Companies - October 28, 2019The RealReal Announces Timing of its Third Quarter 2019 Earnings Results Conference CallSAN FRANCISCO, Oct. 28, 2019 (GLOBE NEWSWIRE) — The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, consigned luxury […]Read More
0 NASDAQ Companies - October 28, 2019MKS Instruments to Present at the Robert W. Baird & Co. 2019 Global Industrial ConferenceANDOVER, Mass., Oct. 28, 2019 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable […]Read More
0 NASDAQ Companies - October 28, 2019Fortinet Acquires Advanced Endpoint Security Company enSiloSUNNYVALE, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) —Ken Xie, Founder, Chairman of the Board, and CEO, Fortinet“As businesses become more […]Read More
0 NASDAQ Companies - October 28, 2019LPL Financial Welcomes Petricic & Phillips Financial GroupCHARLOTTE, N.C., Oct. 28, 2019 (GLOBE NEWSWIRE) — LPL Financial LLC, a leading retail investment advisory firm and independent broker-dealer, […]Read More
0 NASDAQ Companies - October 28, 2019Net1 to Host Conference Call to Review First Quarter 2020 ResultsJOHANNESBURG, South Africa, Oct. 28, 2019 (GLOBE NEWSWIRE) — Net 1 UEPS Technologies, Inc. (NasdaqGS: UEPS; JSE: NT1) (“Net1”) today […]Read More
0 NASDAQ Companies - October 28, 2019Collectors Universe to Announce First Quarter of Fiscal Year 2020 Financial Results on October 31, 2019NEWPORT BEACH, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) — Collectors Universe, Inc. (NASDAQ: CLCT), a leading provider of value-added authentication […]Read More
0 NASDAQ Companies - October 28, 2019Y-mAbs Announces Positive Omburtamab Clinical DataNEW YORK, Oct. 28, 2019 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the Company or Y-mAbs) (Nasdaq: YMAB) a late-stage clinical […]Read More
0 NASDAQ Companies - October 28, 2019miRagen to Present at the DIA/FDA Oligonucleotide-Based Therapeutics Conference TodayAn overview of its second-generation miR-29 mimicsClinical development of its microRNA inhibitorsBOULDER, Colo., Oct. 28, 2019 (GLOBE NEWSWIRE) — miRagen […]Read More
0 NYSE Companies - October 28, 2019Rafael Pharmaceuticals Reaches Milestone of 25 Active Sites for Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)Cranbury, NJ, Oct. 28, 2019 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing […]Read More
0 NYSE Companies - October 28, 2019UPS Undergoes Major Healthcare Facility Enhancements to Meet Growing Service DemandsATLANTA, Oct. 28, 2019 (GLOBE NEWSWIRE) —More than 1M sq. ft. of facility space added in strategic markets across U.S.France, […]Read More